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clinical snippets
Serum Prognostics
Current clinical and histological 
criteria may not be adequate 
to accurately predict outcome 
in CD30+ primary cutaneous 
lymphoproliferative disorders 
(CD30CLPD). Identification 
of new markers is essential 
because 20% of these 
patients progress to systemic 
involvement or secondary 
lymphoma. In a study of 
CD30CLPD patients, Kadin and 
colleagues found a significant 
positive correlation between 
soluble CD30 (sCD30) levels 
and sCD25, CD40L, secreted 
IL-6, and IL-8. Patients with 
increased sCD30 and sCD25 
levels also exhibited decreased 
survival rates. These results 
offer useful information 
for developing prognostics 
for CD30CLPD patients 
at diagnosis and following 
treatment. See page 703
Bad News for 
Psoriasis Patients
Epidemiological evidence 
that suggests that psoriasis is 
associated with an increased 
frequency of cardiovascular 
risk factors and adverse 
outcomes is accumulating. In a 
study of 44,715 individuals from 
the United Kingdom, Langan 
and colleagues found a strong 
association between psoriasis 
and metabolic syndrome, with 
increasing psoriasis severity 
associated with increasing odds 
of metabolic syndrome. These 
results suggest that metabolic 
syndrome is an important 
comorbidity with psoriasis and 
support increased screenings 
for hypertriglyceridemia 
and raised glucose levels in 
psoriasis patients, particularly 
in those with severe disease. 
See page 556  
Epigenetic Classification
Epigenetic alterations such as DNA methylation cor-
relate with gene expression changes, but there have 
been few studies of these changes in diseased tis-
sues. Roberson and colleagues reported extensive 
global methylation changes in involved psoriatic (PP) 
skin compared with uninvolved psoriatic and normal 
(NN) skin. In addition, a subset of differentially meth-
ylated CpG sites correlated with differential expres-
sion of nearby genes, many of which are upregulated 
in psoriasis. Statistical analyses of these data demon-
strated that differentially methylated sites were useful 
for differentiating PP from NN skin in patients. Treatment response and remission may 
also be predicted using this relatively easy method of DNA analysis. See page 583
Back to Normal
Revertant mosaicism (RM) has previously been 
reported in epidermolysis bullosa and ichthyosis with 
confetti. Lai-Cheong and colleagues investigated 
a case of RM in Kindler syndrome that was caused 
by a homozygous insertion in the gene that encodes 
kindlin-1. Back mutation, gene conversion, and 
intragenic crossover were ruled out as mechanisms of 
corrective genetic change in this patient, and a sec-
ond-site mutation was not identified. Furthermore, 
the mRNA exhibited in vivo reversion. These findings 
support a role for kindlin-1 in skin homeostasis and 
indicate that recovery of this protein results in healthy skin and restoration of integ-
rin activation at the cellular level. See page 730
Widening the Spectrum
More than 60 distinct loss-
of-function mutations in the 
SPINK5 gene have previous-
ly been reported in individu-
als with Netherton syndrome 
(NS). Lacroix and colleagues 
widened the molecular spec-
trum of NS by identifying 
novel causative mutations 
that affect the pre-mRNA 
splicing of SPINK5, which 
encodes the serine prote-
ase inhibitor lymphoepi-
thelial Kazal-type-related inhibitor (LEKTI). The identified recurrent SPINK5 mutation 
(c.891C>T) causes skipping of exon 11; however, patients harboring this mutation still 
produce residual levels of LEKTI domains that retain functional activities despite the 
lack of detectable protein in skin sections. These findings have implications for clinical 
NS diagnostics. See page 575
Journal of Investigative Dermatology (2012) 132, 502. doi:10.1038/jid.2011.474
6
1
638
438 
3
0
9
3
0
0
0
0
18
2
PP versus PN PP versus NN
PN versus NN
Increased
Decreased
674
444
Differentially methylated CpG sites
